Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
14.18
+0.37 (2.68%)
Jun 12, 2026, 3:04 PM CST
Market Cap7.69B -6.4%
Revenue (ttm)3.50B +11.8%
Net Income128.49M
EPS0.23
Shares Out 542.18M
PE Ratio62.62
Forward PE38.32
Dividend0.09 (0.63%)
Ex-Dividend DateMay 12, 2026
Volume11,669,753
Open13.46
Previous Close13.81
Day's Range13.46 - 14.29
52-Week Range13.24 - 30.40
Beta0.42
AnalystsBuy
Price Target30.00 (+111.57%)
Earnings DateAug 25, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatograph... [Read more]

Sector Healthcare
Founded 2005
Employees 4,359
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements